For Immediate Release
23 August 2011
HYGEA VCT plc
('Hygea' or the 'Company')
Update on Portfolio Company
The Board of Hygea announces that, as anticipated in the Chairman's statement
accompanying the announcement of the Company's results for the half year ended
30 June 2011, it has today received a further payment in respect of the earnout
provisions included in the sale agreement in respect of its holding in DxS
Limited. Hygea has received £218,000; the total proceeds received to date from
the sale of this investment are now £4.325million against the original cost of
£325,000. In addition, we expect to receive later this year, as previously
reported, the second tranche of the escrow monies amounting to approximately
£300,000.
Enquiries:
James Otter, Hygea vct plc -james.otter@ellipson.co.uk
Charles Breese, Hygea vct plc on 01280 703482 orlarpentnewton@btinternet.com
website:www.hygeavct.com
Roland Cornish, Beaumont Cornish Limited on 020 7628 3396
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Hygea VCT plc via Thomson Reuters ONE
[HUG#1540470]
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.